Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319597748> ?p ?o ?g. }
- W4319597748 endingPage "1078" @default.
- W4319597748 startingPage "1078" @default.
- W4319597748 abstract "Purpose: Develop and validate an accessible prediction model using machine learning (ML) to predict the risk of chemotherapy-induced myelosuppression (CIM) in children with Wilms’ tumor (WT) before chemotherapy is administered, enabling early preventive management. Methods: A total of 1433 chemotherapy cycles in 437 children with WT who received chemotherapy in our hospital from January 2009 to March 2022 were retrospectively analyzed. Demographic data, clinicopathological characteristics, hematology and blood biochemistry baseline results, and medication information were collected. Six ML algorithms were used to construct prediction models, and the predictive efficacy of these models was evaluated to select the best model to predict the risk of grade ≥ 2 CIM in children with WT. A series of methods, such as the area under the receiver operating characteristic curve (AUROC), the calibration curve, and the decision curve analysis (DCA) were used to test the model’s accuracy, discrimination, and clinical practicability. Results: Grade ≥ 2 CIM occurred in 58.5% (839/1433) of chemotherapy cycles. Based on the results of the training and validation cohorts, we finally identified that the extreme gradient boosting (XGB) model has the best predictive efficiency and stability, with an AUROC of up to 0.981 in the training set and up to 0.896 in the test set. In addition, the calibration curve and the DCA showed that the XGB model had the best discrimination and clinical practicability. The variables were ranked according to the feature importance, and the five variables contributing the most to the model were hemoglobin (Hgb), white blood cell count (WBC), alkaline phosphatase, coadministration of highly toxic chemotherapy drugs, and albumin. Conclusions: The incidence of grade ≥ 2 CIM was not low in children with WT, which needs attention. The XGB model was developed to predict the risk of grade ≥ 2 CIM in children with WT for the first time. The model has good predictive performance and stability and has the potential to be translated into clinical applications. Based on this modeling and application approach, the extension of CIM prediction models to other pediatric malignancies could be expected." @default.
- W4319597748 created "2023-02-09" @default.
- W4319597748 creator A5018601417 @default.
- W4319597748 creator A5026418222 @default.
- W4319597748 creator A5027925018 @default.
- W4319597748 creator A5028614369 @default.
- W4319597748 creator A5039412958 @default.
- W4319597748 creator A5042545750 @default.
- W4319597748 creator A5060470951 @default.
- W4319597748 creator A5061460592 @default.
- W4319597748 creator A5063131315 @default.
- W4319597748 creator A5077838824 @default.
- W4319597748 date "2023-02-08" @default.
- W4319597748 modified "2023-09-26" @default.
- W4319597748 title "Development of a Machine Learning-Based Prediction Model for Chemotherapy-Induced Myelosuppression in Children with Wilms’ Tumor" @default.
- W4319597748 cites W1641876683 @default.
- W4319597748 cites W1773441184 @default.
- W4319597748 cites W1804059878 @default.
- W4319597748 cites W1811706705 @default.
- W4319597748 cites W1869649855 @default.
- W4319597748 cites W1874346921 @default.
- W4319597748 cites W1941807065 @default.
- W4319597748 cites W1993941594 @default.
- W4319597748 cites W2023099741 @default.
- W4319597748 cites W2023291563 @default.
- W4319597748 cites W2026417873 @default.
- W4319597748 cites W2031497779 @default.
- W4319597748 cites W2045938015 @default.
- W4319597748 cites W2055672209 @default.
- W4319597748 cites W2061551675 @default.
- W4319597748 cites W2072206857 @default.
- W4319597748 cites W2080127375 @default.
- W4319597748 cites W2082480253 @default.
- W4319597748 cites W2082535104 @default.
- W4319597748 cites W2096138651 @default.
- W4319597748 cites W2133427336 @default.
- W4319597748 cites W2156071129 @default.
- W4319597748 cites W2163491269 @default.
- W4319597748 cites W2217407321 @default.
- W4319597748 cites W2273920155 @default.
- W4319597748 cites W2333034619 @default.
- W4319597748 cites W2543318440 @default.
- W4319597748 cites W2599305812 @default.
- W4319597748 cites W2601774277 @default.
- W4319597748 cites W2606339871 @default.
- W4319597748 cites W2724768039 @default.
- W4319597748 cites W2743170761 @default.
- W4319597748 cites W2794982179 @default.
- W4319597748 cites W2797418481 @default.
- W4319597748 cites W2802241849 @default.
- W4319597748 cites W2802433006 @default.
- W4319597748 cites W2892571161 @default.
- W4319597748 cites W2901885843 @default.
- W4319597748 cites W2902208117 @default.
- W4319597748 cites W2990196239 @default.
- W4319597748 cites W3023985074 @default.
- W4319597748 cites W3037082682 @default.
- W4319597748 cites W3041070518 @default.
- W4319597748 cites W3081311033 @default.
- W4319597748 cites W3093651211 @default.
- W4319597748 cites W3111700213 @default.
- W4319597748 cites W3144747894 @default.
- W4319597748 cites W3162086187 @default.
- W4319597748 cites W3163720257 @default.
- W4319597748 cites W3179752816 @default.
- W4319597748 cites W3200707343 @default.
- W4319597748 cites W3212559860 @default.
- W4319597748 cites W38000034 @default.
- W4319597748 cites W4200197704 @default.
- W4319597748 cites W4200441182 @default.
- W4319597748 cites W4224309796 @default.
- W4319597748 doi "https://doi.org/10.3390/cancers15041078" @default.
- W4319597748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36831423" @default.
- W4319597748 hasPublicationYear "2023" @default.
- W4319597748 type Work @default.
- W4319597748 citedByCount "0" @default.
- W4319597748 crossrefType "journal-article" @default.
- W4319597748 hasAuthorship W4319597748A5018601417 @default.
- W4319597748 hasAuthorship W4319597748A5026418222 @default.
- W4319597748 hasAuthorship W4319597748A5027925018 @default.
- W4319597748 hasAuthorship W4319597748A5028614369 @default.
- W4319597748 hasAuthorship W4319597748A5039412958 @default.
- W4319597748 hasAuthorship W4319597748A5042545750 @default.
- W4319597748 hasAuthorship W4319597748A5060470951 @default.
- W4319597748 hasAuthorship W4319597748A5061460592 @default.
- W4319597748 hasAuthorship W4319597748A5063131315 @default.
- W4319597748 hasAuthorship W4319597748A5077838824 @default.
- W4319597748 hasBestOaLocation W43195977481 @default.
- W4319597748 hasConcept C119857082 @default.
- W4319597748 hasConcept C126322002 @default.
- W4319597748 hasConcept C143998085 @default.
- W4319597748 hasConcept C154945302 @default.
- W4319597748 hasConcept C2775999222 @default.
- W4319597748 hasConcept C2776694085 @default.
- W4319597748 hasConcept C2778488018 @default.
- W4319597748 hasConcept C41008148 @default.
- W4319597748 hasConcept C58471807 @default.
- W4319597748 hasConcept C71924100 @default.